ReviewPharmaceutics2024

Edaravone for the Treatment of Motor Neurone Disease: A Critical Review of Approved and Alternative Formulations against a Proposed Quality Target Product Profile.

Riuna O'Neill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.